Asthika Goonewardene

Work

Analyst Asthika Goonewardene works at TRUIST and is focused on the Healthcare sector with 92 price targets and ratings documented since 2020 spanning on 14 stocks. Analyst's average stock valuation to be materialised ratio is 24.88% with an average time for price targets to be met of 81.17 days.

Most recent stock forecast was given on STRO, Sutro Biopharma, Inc at 13-Jan-2023.

Asthika Goonewardene best performing recommendations are on CELU.
The best stock recommendation documented was for ALLO (ALLOGENE THERAPEUTICS, INC) at 4/13/2020. The price target of $29 was fulfilled within 11 days with a profit of $5.58 (23.83%) receiving and performance score of 21.66.

Average potential price target upside

ALLO CELU CGEN EXEL GMAB HARP IGMS IOVA STRO TCRR HOOK NXTC AUTL TIL

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Hold

12

$3.79 (46.16%)

11

29 days ago

1/2 (50%)

$4.3 (64.63%)

18

Buy

9

$0.79 (9.62%)

32

1 months 23 days ago

0/3 (0%)

$9.9 (62.44%)

Buy

18

$9.79 (119.24%)

4 months 13 days ago

0/5 (0%)

$17.14 (114.54%)

Buy

13

5 months 25 days ago

3/5 (60%)

$5.98 (31.80%)

173

Buy

35

$26.79 (326.31%)

40

5 months 25 days ago

2/7 (28.57%)

$16.51 (79.07%)

194

Show more analysts
ALLO CELU CGEN EXEL GMAB HARP IGMS IOVA STRO TCRR HOOK NXTC AUTL TIL